Literature DB >> 27704174

CFTR pharmacology.

Olga Zegarra-Moran1, Luis J V Galietta2.   

Abstract

CFTR protein is an ion channel regulated by cAMP-dependent phosphorylation and expressed in many types of epithelial cells. CFTR-mediated chloride and bicarbonate secretion play an important role in the respiratory and gastrointestinal systems. Pharmacological modulators of CFTR represent promising drugs for a variety of diseases. In particular, correctors and potentiators may restore the activity of CFTR in cystic fibrosis patients. Potentiators are also potentially useful to improve mucociliary clearance in patients with chronic obstructive pulmonary disease. On the other hand, CFTR inhibitors may be useful to block fluid and electrolyte loss in secretory diarrhea and slow down the progression of polycystic kidney disease.

Entities:  

Keywords:  CFTR; Channel blocker; Chloride channel; Cystic fibrosis

Mesh:

Substances:

Year:  2016        PMID: 27704174     DOI: 10.1007/s00018-016-2392-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  104 in total

1.  Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity.

Authors:  Zhiwei Cai; David N Sheppard
Journal:  J Biol Chem       Date:  2002-03-19       Impact factor: 5.157

2.  A potentiator induces conformational changes on the recombinant CFTR nucleotide binding domains in solution.

Authors:  Elena Galfrè; Lauretta Galeno; Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2012-07-03       Impact factor: 9.261

3.  Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein.

Authors:  B Illek; L Zhang; N C Lewis; R B Moss; J Y Dong; H Fischer
Journal:  Am J Physiol       Date:  1999-10

4.  Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells.

Authors:  Maria Favia; Maria T Mancini; Valentino Bezzerri; Lorenzo Guerra; Onofrio Laselva; Anna C Abbattiscianni; Lucantonio Debellis; Stephan J Reshkin; Roberto Gambari; Giulio Cabrini; Valeria Casavola
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-09       Impact factor: 5.464

5.  Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists.

Authors:  L V Galietta; S Jayaraman; A S Verkman
Journal:  Am J Physiol Cell Physiol       Date:  2001-11       Impact factor: 4.249

6.  Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis.

Authors:  N D Sonawane; A S Verkman
Journal:  Bioorg Med Chem       Date:  2008-07-23       Impact factor: 3.641

7.  Full-open and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics.

Authors:  Jean-Paul Mornon; Brice Hoffmann; Slavica Jonic; Pierre Lehn; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2014-10-07       Impact factor: 9.261

8.  Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Authors:  Tsukasa Okiyoneda; Guido Veit; Johanna F Dekkers; Miklos Bagdany; Naoto Soya; Haijin Xu; Ariel Roldan; Alan S Verkman; Mark Kurth; Agnes Simon; Tamas Hegedus; Jeffrey M Beekman; Gergely L Lukacs
Journal:  Nat Chem Biol       Date:  2013-05-12       Impact factor: 15.040

9.  Use of kinase inhibitors to correct ΔF508-CFTR function.

Authors:  Agata M Trzcinska-Daneluti; Leo Nguyen; Chong Jiang; Christopher Fladd; David Uehling; Michael Prakesch; Rima Al-awar; Daniela Rotin
Journal:  Mol Cell Proteomics       Date:  2012-06-14       Impact factor: 7.381

10.  Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker.

Authors:  Alessandro Taddei; Chiara Folli; Olga Zegarra-Moran; Pascale Fanen; A S Verkman; Luis J V Galietta
Journal:  FEBS Lett       Date:  2004-01-30       Impact factor: 4.124

View more
  15 in total

1.  Conformational change of the extracellular parts of the CFTR protein during channel gating.

Authors:  Alexander Negoda; Elizabeth A Cowley; Yassine El Hiani; Paul Linsdell
Journal:  Cell Mol Life Sci       Date:  2018-02-14       Impact factor: 9.261

2.  Small molecule-facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosis.

Authors:  Michele Fiore; Claudia Cossu; Valeria Capurro; Cristiana Picco; Alessandra Ludovico; Marcin Mielczarek; Israel Carreira-Barral; Emanuela Caci; Debora Baroni; Roberto Quesada; Oscar Moran
Journal:  Br J Pharmacol       Date:  2019-04-23       Impact factor: 8.739

3.  Oxalate secretion is stimulated by a cAMP-dependent pathway in the mouse cecum.

Authors:  Jonathan M Whittamore; Marguerite Hatch
Journal:  Pflugers Arch       Date:  2022-08-31       Impact factor: 4.458

4.  Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro.

Authors:  Ciaran A Shaughnessy; Pamela L Zeitlin; Preston E Bratcher
Journal:  J Cyst Fibros       Date:  2022-03-02       Impact factor: 5.527

5.  Anion-Transport Mechanism of a Triazole-Bearing Derivative of Prodigiosine: A Candidate for Cystic Fibrosis Therapy.

Authors:  Claudia Cossu; Michele Fiore; Debora Baroni; Valeria Capurro; Emanuela Caci; Maria Garcia-Valverde; Roberto Quesada; Oscar Moran
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

6.  Exome sequencing of Saudi Arabian patients with ADPKD.

Authors:  Fahad A Al-Muhanna; Abdullah M Al-Rubaish; Chittibabu Vatte; Shamim Shaikh Mohiuddin; Cyril Cyrus; Arafat Ahmad; Mohammed Shakil Akhtar; Mohammad Ahmad Albezra; Rudaynah A Alali; Afnan F Almuhanna; Kai Huang; Lusheng Wang; Feras Al-Kuwaiti; Tamer S Ahmed Elsalamouni; Abdullah Al Hwiesh; Xiaoyan Huang; Brendan Keating; Jiankang Li; Matthew B Lanktree; Amein K Al-Ali
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

7.  Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity.

Authors:  Andrea Armirotti; Valeria Tomati; Elizabeth Matthes; Guido Veit; Deborah M Cholon; Puay-Wah Phuan; Clarissa Braccia; Daniela Guidone; Martina Gentzsch; Gergely L Lukacs; Alan S Verkman; Luis J V Galietta; John W Hanrahan; Nicoletta Pedemonte
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

8.  Correctors modify the bicarbonate permeability of F508del-CFTR.

Authors:  Michele Fiore; Cristiana Picco; Oscar Moran
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

Review 9.  Cystic fibrosis transmembrane conductance regulator (CFTR): Making an ion channel out of an active transporter structure.

Authors:  Paul Linsdell
Journal:  Channels (Austin)       Date:  2018       Impact factor: 2.581

Review 10.  Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.

Authors:  Anna Esposito; Daniele D'Alonzo; Maria De Fenza; Eliana De Gregorio; Anna Tamanini; Giuseppe Lippi; Maria Cristina Dechecchi; Annalisa Guaragna
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.